CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings/ (Deficit) [Member]
Beginning Balance, Amount at Dec. 31, 2017	$ (7,981,509)	$ 671,583	$ (8,653,092)
Beginning Balance, Shares at Dec. 31, 2017		69,158,308
Restricted stock awards granted	79,083		79,083
Stock options granted	59,003		59,003
Net income (loss)	(734,967)			$ (734,967)
Ending Balance, Amount at Mar. 31, 2018	(8,578,390)	$ 671,583	(8,515,006)	(734,967)
Ending Balance, Shares at Mar. 31, 2018		69,158,308
Beginning Balance, Amount at Dec. 31, 2017	(7,981,509)	$ 671,583	(8,653,092)
Beginning Balance, Shares at Dec. 31, 2017		69,158,308
Net income (loss)	(2,073,082)
Ending Balance, Amount at Sep. 30, 2018	(5,007,404)	$ 713,688	(3,648,010)	(2,073,082)
Ending Balance, Shares at Sep. 30, 2018		73,368,835
Beginning Balance, Amount at Mar. 31, 2018	(8,578,390)	$ 671,583	(8,515,006)	(734,967)
Beginning Balance, Shares at Mar. 31, 2018		69,158,308
Restricted stock awards granted	79,083		79,083
Stock options granted	167,313		167,313
CPM working capital purchase price adjustment	(397,463)		(397,463)
Inventory capital transaction	1,547,807		1,547,807
Net income (loss)	(1,615,297)			(1,615,297)
Ending Balance, Amount at Jun. 30, 2018	(8,796,947)	$ 671,583	(7,118,266)	(2,350,264)
Ending Balance, Shares at Jun. 30, 2018		69,158,308
Restricted stock awards granted	52,722		52,722
Stock options granted	259,639		259,639
Purchase of Maxim Surgical	3,200,000	$ 42,105	3,157,895
Purchase of Maxim Surgical, Shares		4,210,527
Net income (loss)	277,182			277,182
Ending Balance, Amount at Sep. 30, 2018	(5,007,404)	$ 713,688	(3,648,010)	(2,073,082)
Ending Balance, Shares at Sep. 30, 2018		73,368,835
Beginning Balance, Amount at Dec. 31, 2018	1,466,684	$ 714,891		751,793
Beginning Balance, Shares at Dec. 31, 2018		74,600,181
Stock options granted	244,407		244,407
Net income (loss)	(510,998)			(510,998)
Ending Balance, Amount at Mar. 31, 2019	1,200,093	$ 714,891	244,407	240,795
Ending Balance, Shares at Mar. 31, 2019		74,600,181
Beginning Balance, Amount at Dec. 31, 2018	1,466,684	$ 714,891		751,793
Beginning Balance, Shares at Dec. 31, 2018		74,600,181
Net income (loss)	(4,717,489)
Ending Balance, Amount at Sep. 30, 2019	(2,763,281)	$ 714,891	487,524	(3,965,696)
Ending Balance, Shares at Sep. 30, 2019		74,600,181
Beginning Balance, Amount at Mar. 31, 2019	1,200,093	$ 714,891	244,407	240,795
Beginning Balance, Shares at Mar. 31, 2019		74,600,181
Stock options granted	254,700		254,700
Net income (loss)	(142,149)			(142,149)
Ending Balance, Amount at Jun. 30, 2019	1,312,644	$ 714,891	499,107	98,646
Ending Balance, Shares at Jun. 30, 2019		74,600,181
Stock options granted	(11,583)		(11,583)
Net income (loss)	(4,064,342)			(4,064,342)
Ending Balance, Amount at Sep. 30, 2019	$ (2,763,281)	$ 714,891	$ 487,524	$ (3,965,696)
Ending Balance, Shares at Sep. 30, 2019		74,600,181